# Half-Dose Flu Vaccine Study in Healthy Adults

> **NCT00006146** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 840 (—)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Approved influenza virus vaccine.

## Key facts

- **NCT ID:** NCT00006146
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-08
- **Primary completion:** —
- **Final completion:** 2000-09
- **Target enrollment:** 840 (—)
- **Last updated:** 2010-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006146, "Half-Dose Flu Vaccine Study in Healthy Adults". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00006146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*